Ginsenoside Rh4
CAS: 174721-08-5
Ref. TM-T6S1485
| 1mg | 152.00 € | ||
| 5mg | 323.00 € | ||
| 10mg | 498.00 € | ||
| 25mg | 865.00 € | ||
| 50mg | To inquire | ||
| 1mL*10mM (DMSO) | 385.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
Product Information
Name:
Ginsenoside Rh4
Synonyms:
- (3β,6α,12β,20E)-3,12-Dihydroxydammara-20(22),24-dien-6-yl β-<span class="text-smallcaps">D</span>-glucopyranoside
- Ginsenoside Rh<sub>4</sub>
- beta-D-glucopyranoside, (3beta,6alpha,12beta,20E)-3,12-dihydroxydammara-20(22),24-dien-6-yl
- β-<span class="text-smallcaps">D</span>-Glucopyranoside, (3β,6α,12β,20E)-3,12-dihydroxydammara-20(22),24-dien-6-yl
Description:
Ginsenoside Rh4, a non-haemolytic adjuvant, exhibits cytotoxic effects on cancer cells.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
620.86
Formula:
C36H60O8
Purity:
95% - 98.67%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T6S1485 Ginsenoside Rh4
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
